---
title: 'S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update
  2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment
  of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention'
date: '2023-10-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37840404/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231016181012&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Actinic keratosis (AK) are common lesions in light-skinned individuals
  that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both
  conditions may be associated with significant morbidity and constitute a major disease
  burden, especially among the elderly. To establish an evidence-based framework for
  clinical decision making, the guideline "actinic keratosis and cutaneous squamous
  cell carcinoma" was updated and expanded by the topics cutaneous squamous cell carcinoma
  in ...
disable_comments: true
---
Actinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline "actinic keratosis and cutaneous squamous cell carcinoma" was updated and expanded by the topics cutaneous squamous cell carcinoma in ...